Cited by 217Atrial Fibrillation Management and OutcomesBlood Coagulation and Thrombosis MechanismsBlood transfusion and management

The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.

Warfarin reversal

Open access

Hanley, J P·2004·Journal of Clinical Pathology

DOI 10.1136/jcp.2003.008904PMC PMC1770479

Open this paper in CoChat — free account Open PDF

Abstract

Warfarin is the most commonly used oral anticoagulant in the UK. It is associated with few side effects apart from haemorrhage. The most appropriate way to reverse the anticoagulant effect of warfarin depends on the clinical circumstances. In serious bleeding, rapid reversal is required, whereas in minor bleeding or asymptomatic over anticoagulation, a more leisurely approach is usually appropriate. This review discusses the current approaches to warfarin reversal in clinical practice. The development of a uniform approach to warfarin reversal in the Northern Region is described.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1136/jcp.2003.008904

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)
Palareti, G., Leali, N., COCCHERI, S., Poggi, M., Manotti, C., D’Angelo, A., Pengo, V., Erba, N., Moia, M., CIAVARELLA, N., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)01109-9 · Cited by 1,319
Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications
Aithal, G. P., Day, C. P., Kesteven, P. J., & Daly, A. K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)04474-2 · Cited by 1,239
Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin
Hylek, E. M., & Singer, D. E. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-11-199406010-00001 · Cited by 915
Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention
Landefeld, C. S., & Beyth, R. J. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90285-w · Cited by 897
Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin
Beyth, R. J., Quinn, L., & Landefeld, C. S. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00198-3 · Cited by 777
Risk Factors for Complications of Chronic Anticoagulation: A Multicenter Study
Fihn, S. D., McDonell, M., Martin, D., Henikoff, J. G., Vermes, D., Kent, D., White, R. H., & for the Warfarin Optimized Outpatient Follow-up Study Group* (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-7-199304010-00005 · Cited by 670
Managing Oral Anticoagulant Therapy
Ansell, J., Hirsh, J., Dalen, J. E., Bussey, H. I., Anderson, D., Poller, L., Jacobson, A. K., Deykin, D., & Matchar, D. B. (2001) · CHEST Journal · doi:10.1378/chest.119.1_suppl.22s · Cited by 576
Oral Anticoagulants and Intracranial Hemorrhage
Hart, R. G., Boop, B. S., & Anderson, D. C. (1995) · Stroke · doi:10.1161/01.str.26.8.1471 · Cited by 545
Bleeding complications in oral anticoagulant therapy. An analysis of risk factors
van der Meer, F. J. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.13.1557 · Cited by 539
Bleeding Complications in Oral Anticoagulant Therapy
van der Meer, F. J. M. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410130073007 · Cited by 435

Show all 76 references

Research works printed but not linked: 2

2003, Br J Gen Pract, 53, 312
2002, Med Sci Monit, 8, 98

Sorted by citations

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
Hemphill, J. C., Greenberg, S. M., Anderson, C. S., Becker, K. J., Bendok, B. R., Cushman, M., Fung, G. L., Goldstein, J. N., Macdonald, R. L., Mitchell, P. H., et al. (2015) · Stroke · doi:10.1161/str.0000000000000069 · Cited by 4,053
The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients
Costanzo, M. R., Costanzo, M. R., Dipchand, A. I., Starling, R. C., Anderson, A. S., Chan, M. C. Y., Desai, S., Fedson, S., Fisher, P. W., Gonzales-Stawinski, G. V., et al. (2010) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2010.05.034 · Cited by 1,663
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
Morgenstern, L. B., Hemphill, J. C., Anderson, C. S., Becker, K. J., Broderick, J. P., Connolly, E. S., Greenberg, S. M., Huang, J. N., Macdonald, R. L., Messe, S. R., et al. (2010) · Stroke · doi:10.1161/str.0b013e3181ec611b · Cited by 1,501
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403
Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation
Heidbüchel, H., Verhamme, P. B., Alings, M., Antz, M., Diener, H., Hacke, W., Oldgren, J., Sinnaeve, P., Camm, A. J., & Kirchhof, P. F. (2015) · EP Europace · doi:10.1093/europace/euv309 · Cited by 1,129
Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage
Frontera, J. A., Lewin, J. J., Rabinstein, A. A., Aisiku, I. P., Alexandrov, A. W., Cook, A. M., del Zoppo, G. J., Kumar, M. A., Peerschke, E. I. B., Stiefel, M., et al. (2015) · Neurocritical Care · doi:10.1007/s12028-015-0222-x · Cited by 725
The surgical management of chronic subdural hematoma
Ducruet, A. F., Grobelny, B. T., Zacharia, B. E., Hickman, Z. L., DeRosa, P., Anderson, K., Sussman, E. S., Carpenter, A. B., & Connolly, E. S. (2011) · Neurosurgical Review · doi:10.1007/s10143-011-0349-y · Cited by 529
The increasing incidence of anticoagulant-associated intracerebral hemorrhage
Flaherty, M. L., D, B. M. K. M., Woo, D., Kleindorfer, D., Alwell, K., Sekar, P., Moomaw, C. J., Haverbusch, M. A., & Broderick, J. P. (2007) · Neurology · doi:10.1212/01.wnl.0000250340.05202.8b · Cited by 477
Therapeutic strategies for thrombosis: new targets and approaches
Mackman, N., Bergmeier, W., Stouffer, G. A., & Weitz, J. I. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0061-0 · Cited by 413
Role of prothrombin complex concentrates in reversing warfarin anticoagulation: A review of the literature
Leissinger, C., Blatt, P. M., Hoots, W. K., & Ewenstein, B. M. (2007) · American Journal of Hematology · doi:10.1002/ajh.21046 · Cited by 343
Hematoma Growth and Outcome in Treated Neurocritical Care Patients With Intracerebral Hemorrhage Related to Oral Anticoagulant Therapy
Huttner, H. B., Schellinger, P. D., Hartmann, M., Köhrmann, M., Jüettler, E., Wikner, J., Mueller, S., Meyding‐Lamadé, U., Strobl, R., Mansmann, U., et al. (2006) · Stroke · doi:10.1161/01.str.0000221786.81354.d6 · Cited by 334
Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial
Glund, S., Stangier, J., Schmohl, M., Ganßer, D., Norris, S. H., van Ryn, J., Lang, B. J., Ramael, S., Moschetti, V., Gruenenfelder, F. I., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60732-2 · Cited by 318
Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents
Crowther, M. A., & Warkentin, T. E. (2008) · Blood · doi:10.1182/blood-2007-10-120543 · Cited by 311
Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists
Marchesi, C., Giorgi‐Pierfranceschi, M., Crowther, M. A., Garcia, D. A., Hylek, E. M., Witt, D. M., Clark, N. P., Squizzato, A., Imberti, D., Ageno, W., et al. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-01-0052 · Cited by 307
Intracerebral Hemorrhage Associated With Oral Anticoagulant Therapy
Steiner, T., Rosand, J. M., & Diringer, M. N. (2005) · Stroke · doi:10.1161/01.str.0000196989.09900.f8 · Cited by 297
Evidence based diagnosis and management of chronic subdural hematoma: A review of the literature
Mehta, V. A., Harward, S. C., Sankey, E. W., Nayar, G., & Codd, P. J. (2018) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2018.01.050 · Cited by 240
Prothrombin complex concentrates: an update.
Franchini, M., & Lippi, G. (2010) · Europe PMC (PubMed Central) · doi:10.2450/2010.0149-09 · Cited by 203
Management consensus guidance for the use of rivaroxaban – an oral, direct factor Xa inhibitor
Kreutz, R. H., Llau, J. V., Norrving, B. G., Haas, S. K., & Turpie, A. G. G. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-03-0209 · Cited by 169
Anticoagulants: A Short History, Their Mechanism of Action, Pharmacology, and Indications
Heestermans, M., Poénou, G., Hamzeh‐Cognasse, H., Cognasse, F., & Bertoletti, L. (2022) · Cells · doi:10.3390/cells11203214 · Cited by 161
Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding
Schick, K. S., Fertmann, J. M., Jauch, K., & Hoffmann, J. N. (2009) · Critical Care · doi:10.1186/cc8186 · Cited by 125
Progression of warfarin-associated intracerebral hemorrhage after INR normalization with FFP
Lee, S. B., Manno, E. M., Layton, K. F., & Wijdicks, E. F. M. (2006) · Neurology · doi:10.1212/01.wnl.0000238104.75563.2f · Cited by 113
Oral anticoagulant-associated intracerebral hemorrhage
Cervera, Á., Amaro, S., & Chamorro, Á. (2011) · Journal of Neurology · doi:10.1007/s00415-011-6153-3 · Cited by 101
Long-term safety and efficacy of a pasteurized nanofiltrated prothrombin complex concentrate (Beriplex P/N): a pharmacovigilance study
Hanke, A., Joch, C., & Görlinger, K. (2013) · British Journal of Anaesthesia · doi:10.1093/bja/aes501 · Cited by 93
Emergency Neurological Life Support: Intracerebral Hemorrhage
Jauch, E. C., Pineda, J., & Hemphill, J. C. (2015) · Neurocritical Care · doi:10.1007/s12028-015-0167-0 · Cited by 86
Hemostatic and hemorrhagic problems in neurosurgical patients
Gerlach, R., Krause, M., Seifert, V., & Goerlinger, K. (2009) · Acta Neurochirurgica · doi:10.1007/s00701-009-0409-z · Cited by 79
Prothrombin complex concentrate versus recombinant factor VIIa for reversal of coumarin anticoagulation
Dickneite, G. (2006) · Thrombosis Research · doi:10.1016/j.thromres.2006.05.011 · Cited by 79
Hereditary combined deficiency of the vitamin K-dependent clotting factors
Napolitano, M., Mariani, G., & Lapecorella, M. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-21 · Cited by 79
Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathy
Wójcik, C., Schymik, M. L., & Cure, E. G. (2009) · International Journal of Emergency Medicine · doi:10.1007/s12245-009-0125-8 · Cited by 77
Reversal of Elevated International Normalized Ratios and Bleeding with Low‐Dose Recombinant Activated Factor VII in Patients Receiving Warfarin
Dager, W. E., King, J. H., Regalia, R. C., Williamson, D., Gosselin, R. C., White, R. H. R., Tharratt, R. S., & Albertson, T. E. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.8.1091 · Cited by 74
Warfarin-induced bleeding complications — clinical presentation and therapeutic options
Wiedermann, C. J., & Stockner, I. (2008) · Thrombosis Research · doi:10.1016/s0049-3848(08)70004-5 · Cited by 74
Acute Traumatic Brain Injury: Mortality in the Elderly
Herou, E., Romner, B., & Tomasevic, G. (2015) · World Neurosurgery · doi:10.1016/j.wneu.2015.02.023 · Cited by 73
Atrial fibrillation in Sub-Saharan Africa: epidemiology, unmet needs, and treatment options
Stambler, B. S., & Ngunga, L. M. (2015) · International Journal of General Medicine · doi:10.2147/ijgm.s84537 · Cited by 73
Epidemiological characteristics of 778 patients who underwent surgical drainage of chronic subdural hematomas in Brasília, Brazil
Sousa, E. B., Brandão, L. F. D. S., Tavares, C. B., Borges, I. B. C., Neto, N. G. F., & Kessler, I. M. (2013) · BMC Surgery · doi:10.1186/1471-2482-13-5 · Cited by 72
Antivitamins for Medicinal Applications
Zelder, F., Sonnay, M., & Prieto, L. (2015) · ChemBioChem · doi:10.1002/cbic.201500072 · Cited by 71
Exploratory study on the reversal of warfarin with rFVIIa in healthy subjects
Skolnick, B. E., Mathews, D. R., Khutoryansky, N., Pusateri, A. E., & Carr, M. E. (2010) · Blood · doi:10.1182/blood-2009-11-253492 · Cited by 70
Current and future strategies to monitor and manage coagulation in ECMO patients
Shirejini, S. Z., Carberry, J., McQuilten, Z., Burrell, A. J. C., Gregory, S. D., & Hagemeyer, C. E. (2023) · Thrombosis Journal · doi:10.1186/s12959-023-00452-z · Cited by 70
How I treat warfarin-associated coagulopathy in patients with intracerebral hemorrhage
Goodnough, L. T., & Shander, A. (2011) · Blood · doi:10.1182/blood-2010-11-316075 · Cited by 67
Benefits and harms of 4-factor prothrombin complex concentrate for reversal of vitamin K antagonist associated bleeding: a systematic review and meta-analysis
Brekelmans, M. P. A., van Ginkel, K., Daams, J. G., Hutten, B. A., Middeldorp, S., & Coppens, M. (2017) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-017-1506-0 · Cited by 66
Pentadecapeptide BPC 157 reduces bleeding time and thrombocytopenia after amputation in rats treated with heparin, warfarin or aspirin
Stupnišek, M., Franjić, S., Drmić, D., Patrlj, M. H., Kolenc, D., Radić, B., Bojić, D., Včev, A., Seiwerth, S., & Sikirić, P. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.07.035 · Cited by 63
What Is the Evidence for the Off-label Use of Recombinant Factor VIIa (rFVIIa) in the Acute Reversal of Warfarin?
Rosovsky, R. P. G., & Crowther, M. A. (2008) · Hematology · doi:10.1182/asheducation-2008.1.36 · Cited by 63
Factor IX complex for the correction of traumatic coagulopathy
Joseph, B. A., Amini, A., Friese, R. S., Houdek, M. T., Hays, D. P., Kulvatunyou, N., Wynne, J. L., O’Keeffe, T., Latifi, R., & Rhee, P. (2012) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e318247c944 · Cited by 62
Guías de actuación clínica en la hemorragia intracerebral
Rodríguez‐Yáñez, M., Castellanos, M., Freijo, M. D. M., Fernández, J. C. L., Martí‐Fábregas, J., Nombela, F., Simal, P., Castillo, J., Díez‐Tejedor, E., Fuentes, B., et al. (2011) · Neurología · doi:10.1016/j.nrl.2011.03.010 · Cited by 65
Emergency Neurological Life Support: Intracerebral Hemorrhage
Hemphill, J. C., & Lam, A. M. (2017) · Neurocritical Care · doi:10.1007/s12028-017-0453-0 · Cited by 58
The Practical Management of Intracerebral Hemorrhage Associated with Oral Anticoagulant Therapy
Masotti, L., Napoli, M. D., Godoy, D. A., Rafanelli, D., Liumbruno, G. M., Koumpouros, N., Landini, G., Pampana, A., Cappelli, R., Poli, D., et al. (2011) · International Journal of Stroke · doi:10.1111/j.1747-4949.2011.00595.x · Cited by 56
Warfarin and intracranial haemorrhage
Appelboam, R., & Thomas, E. (2008) · Blood Reviews · doi:10.1016/j.blre.2008.05.001 · Cited by 55
Warfarin Reversal in Anticoagulant-Associated Intracerebral Hemorrhage
Goldstein, J. N., Rosand, J. M., & Schwamm, L. H. (2008) · Neurocritical Care · doi:10.1007/s12028-008-9049-z · Cited by 53
Use and effectiveness of prothrombin complex concentrates vs fresh frozen plasma in gastrointestinal hemorrhage due to warfarin usage in the ED
Karaca, M. A., Erbil, B., & Özmen, M. M. (2014) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2014.02.016 · Cited by 53
Emergency Neurological Life Support: Intracerebral Hemorrhage
Andrews, C. M., Jauch, E. C., Hemphill, J. C., Smith, W. S., & Weingart, S. D. (2012) · Neurocritical Care · doi:10.1007/s12028-012-9757-2 · Cited by 52
Successful emergency reversal of phenprocoumon anticoagulation with prothrombin complex concentrate: a prospective clinical study
Lorenz, R. L., Kienast, J., Otto, U., Kiehl, M. G., Schreiter, D., Haertel, S., & Barthels, M. (2007) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e3282010d7a · Cited by 48
Effectiveness of Factor IX Complex Concentrate in Reversing Warfarin Associated Coagulopathy for Intracerebral Hemorrhage
Siddiq, F., Jalil, A., McDaniel, C. M., Brock, D. G., Pineda, C. C., BELL, R. D., & Lee, K. (2007) · Neurocritical Care · doi:10.1007/s12028-007-9011-5 · Cited by 47
Treatments for reversing warfarin anticoagulation in patients with acute intracranial hemorrhage: a structured literature review
Bechtel, B. F., Nuñez, T. C., Lyon, J. A., Cotton, B. A., & Barrett, T. W. (2011) · International Journal of Emergency Medicine · doi:10.1186/1865-1380-4-40 · Cited by 46
Treatment of Acute Subdural Hematoma
Gerard, C. S., & Busl, K. M. (2013) · Current Treatment Options in Neurology · doi:10.1007/s11940-013-0275-0 · Cited by 48
An evidence-based warfarin management protocol reduces surgical delay in hip fracture patients
Ahmed, I., Khan, M., Nayak, V. K., & Mohsen, A. (2013) · Journal of Orthopaedics and Traumatology · doi:10.1007/s10195-013-0274-7 · Cited by 44
Massive, Fatal, Intracardiac Thrombosis Associated With Prothrombin Complex Concentrate
Warren, O. U., & Simon, B. (2009) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2008.12.027 · Cited by 43
Short‐term warfarin reversal for elective surgery – using low‐dose intravenous vitamin K: safe, reliable and convenient*
Burbury, K. L., Milner, A. D., Snooks, B., Jupe, D. M. L., & Westerman, D. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08787.x · Cited by 42
Dabigatran bleed risk with closed head injuries: are we prepared?
Parra, M. W., Zucker, L., Johnson, E. S., Gullett, D., Avila, C., Wichner, Z. A., & Kokaram, C. R. (2013) · Journal of neurosurgery · doi:10.3171/2013.3.jns12503 · Cited by 42
A Practical Review of the Emerging Direct Anticoagulants, Laboratory Monitoring, and Reversal Agents
Joppa, S., Salciccioli, J. D., Adamski, J., Patel, S. I., Wysokiński, W. E., McBane, R. D., Al‐Saffar, F., Esser, H., & Shamoun, F. E. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7020029 · Cited by 44
Prothrombin Complex Concentrate Accelerates International Normalized Ratio Reversal and Diminishes the Extension of Intracranial Hemorrhage in Geriatric Trauma Patients
Edavettal, M. M., Rogers, A. T., Rogers, F. B., Horst, M., & Leng, W. (2014) · The American Surgeon · doi:10.1177/000313481408000419 · Cited by 42
Small-molecule binding and sensing with a designed protein family
(2026) · doi:10.1038/s41467-026-70953-8 · Cited by 41
Appraisal of current vitamin K dosing algorithms for the reversal of over‐anticoagulation with warfarin: the need for a more tailored dosing regimen
Sconce, E. A., & Kamali, F. (2006) · European Journal Of Haematology · doi:10.1111/j.0902-4441.2006.t01-1-ejh2957.x · Cited by 41
Clinical practice guidelines in intracerebral haemorrhage
Rodríguez‐Yáñez, M., Castellanos, M., Freijo, M. M., Fernández, J. C. L., Martí‐Fábregas, J., Nombela, F., Simal, P., Castillo, J., Díez‐Tejedor, E., Fuentes, B., et al. (2013) · Neurología (English Edition) · doi:10.1016/j.nrleng.2011.03.011 · Cited by 41
Management dilemmas in patients with mechanical heart valves and warfarin-induced major bleeding
Panduranga, P. (2012) · World Journal of Cardiology · doi:10.4330/wjc.v4.i3.54 · Cited by 39
Benefits and Pitfalls of Point-of-Care Coagulation Testing for Anticoagulation Management
Wool, G. D. (2018) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqy087 · Cited by 38
Warfarin reversal emerging as the major indication for fresh frozen plasma use at a tertiary care hospital
Özgönenel, B., O’Malley, B. A., Krishen, P., & Eisenbrey, A. B. (2007) · American Journal of Hematology · doi:10.1002/ajh.20902 · Cited by 37
An audit of the role of vitamin K in the reversal of International Normalised Ratio (INR) in patients undergoing surgery for hip fracture
Bhatia, M., Talawadekar, G. D., Parihar, S., & Smith, A. J. (2010) · Annals of The Royal College of Surgeons of England · doi:10.1308/003588410x12664192075774 · Cited by 37
A toxicogenomics-based parallelogram approach to evaluate the relevance of coumarin-induced responses in primary human hepatocytes in vitro for humans in vivo
Kienhuis, A. S., van de Poll, M. C. G., Dejong, C. H. C., Gottschalk, R. W. H., van Herwijnen, M. H. M., Boorsma, A., Kleinjans, J. C. S., Stierum, R. H., & van Delft, J. H. M. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.06.005 · Cited by 36
Emergency reversal of anticoagulation: The real use of prothrombin complex concentrates
Desmettre, T., Dubart, A.-E., Capellier, G., Fanara, B., Puyraveau, M., Kepka, S., Coquart, J. B., Sheppard, F., & Tazarourte, K. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.05.029 · Cited by 36
International Normalised Ratio Normalisation in Patients with Coumarin-Related Intracranial Haemorrhages – the INCH Trial: A Randomised Controlled Multicentre Trial to Compare Safety and Preliminary Efficacy of Fresh Frozen Plasma and Prothrombin Complex – Study Design and Protocol
Steiner, T., Freiberger, A., Griebe, M., Hüsing, J., Ivandic, B., Kollmar, R., Pfefferkorn, T., Wartenberg, K. E., Weimar, C., Hennerici, M. G., et al. (2011) · International Journal of Stroke · doi:10.1111/j.1747-4949.2010.00560.x · Cited by 36
Urgent reversal of vitamin K antagonist therapy
Vang, M. L., Hvas, A., & Ravn, H. B. (2011) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2011.02414.x · Cited by 36
A promising new alternative for the rapid reversal of warfarin coagulopathy in traumatic intracranial hemorrhage
Safaoui, M. N., Aazami, R., Hotz, H. A., Wilson, M. T., & Margulies, D. R. (2008) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2008.04.003 · Cited by 36
Point‐of‐care reversal treatment in phenprocoumon‐related intracerebral hemorrhage
Rizos, T., Jenetzky, E., Herweh, C., Hug, A., Hacke, W., Steiner, T., & Veltkamp, R. C. (2010) · Annals of Neurology · doi:10.1002/ana.21965 · Cited by 35
A French multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversal
Kerebel, D., Joly, L., Honnart, D., Schmidt, J., Damien Galanaud, E., Négrier, C., Kursten, F. W., Coriat, P., & Lex206 Investigator Group (2013) · Critical Care · doi:10.1186/cc11923 · Cited by 34
Warfarin-reversal: results of a phase III study with pasteurised, nanofiltrated prothrombin complex concentrate
Pabinger-Fasching, I. (2008) · Thrombosis Research · doi:10.1016/s0049-3848(08)70005-7 · Cited by 34
Anticoagulant Reversal in Gastrointestinal Bleeding: Review of Treatment Guidelines
Milling, T. J., Refaai, M. A., & Sengupta, N. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06728-y · Cited by 36
Efficacy of Warfarin Reversal in Orthopedic Trauma Surgery Patients
Tharmarajah, P., Pusey, J., Keeling, D. M., & Willett, K. M. (2007) · Journal of Orthopaedic Trauma · doi:10.1097/bot.0b013e31802c4f3c · Cited by 34
The headache over warfarin in British neurosurgical intensive care units: a national survey of current practice
Appelboam, R., & Thomas, E. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0765-1 · Cited by 34
Management of Warfarin Anticoagulation in Patients with Fractured Neck of Femur
Ashouri, F., Al-Jundi, W., Patel, A., & Mangwani, J. (2011) · ISRN Hematology · doi:10.5402/2011/294628 · Cited by 33
Reversal of Vitamin K Antagonist (VKA) effect in patients with severe bleeding: a French multicenter observational study (Optiplex) assessing the use of Prothrombin Complex Concentrate (PCC) in current clinical practice
Desmettre, T., Dehours, É., Samama, C. M., Jhundoo, S., Pujeau, F., Guillaudin, C.-H., Hecquart, C., Clerson, P., Crave, J. C., & Jaussaud, R. (2012) · Critical Care · doi:10.1186/cc11669 · Cited by 32
Modulation of neuroinflammation and oxidative stress by targeting GPR55 – new approaches in the treatment of psychiatric disorders
Apweiler, M., Saliba, S. W., Sun, L., Streyczek, J., Normann, C., Hellwig, S., Bräse, S., & Fiebich, B. L. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02614-5 · Cited by 31
Synthesis of conductive polymeric ionic liquid/Ni nanocomposite and its application to construct a nanostructure based electrochemical sensor for determination of warfarin in the presence of tramadol
Molaakbari, E., Mostafavi, A., Beitollahi, H., & Tohidiyan, Z. (2017) · Talanta · doi:10.1016/j.talanta.2017.04.041 · Cited by 30
Proximal femur fractures in patients taking anticoagulants
Papachristos, I. V., & Giannoudis, P. V. (2020) · EFORT Open Reviews · doi:10.1302/2058-5241.5.190071 · Cited by 28
Intracerebral haemorrhage: an often neglected medical emergency
Marietta, M., Pedrazzi, P., Girardis, M., & Torelli, G. (2007) · Internal and Emergency Medicine · doi:10.1007/s11739-007-0009-y · Cited by 28
Treatment and monitoring of coagulation abnormalities in children undergoing heart surgery
Arnold, P. D. (2010) · Pediatric Anesthesia · doi:10.1111/j.1460-9592.2010.03461.x · Cited by 27
Current State of Knowledge on Oral Anticoagulant Reversal Using Procoagulant Factors
Nitzki‐George, D., Wozniak, I., & Caprini, J. A. (2013) · Annals of Pharmacotherapy · doi:10.1345/aph.1r724 · Cited by 27
Dabigatran Etexilate: A Review in Nonvalvular Atrial Fibrillation
Blair, H. A., & Keating, G. M. (2017) · Drugs · doi:10.1007/s40265-017-0699-z · Cited by 29
Warfarin Therapy: Influence of Pharmacogenetic and Environmental Factors on the Anticoagulant Response to Warfarin
Siguret, V., Pautas, É., & Gouin‐Thibault, I. (2008) · Vitamins and hormones · doi:10.1016/s0083-6729(07)00012-x · Cited by 27
Experiences with an activated 4-factor prothrombin complex concentrate (FEIBA) for reversal of warfarin-related bleeding
Stewart, W. S., & Pettit, H. (2013) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2013.05.008 · Cited by 27
Investigating cell type specific mechanisms contributing to acute oral toxicity
Prieto, P. (2018) · ALTEX · doi:10.14573/altex.1805181 · Cited by 26
Pharmacologic Reversal of Warfarin-Associated Coagulopathy in Geriatric Patients With Hip Fractures
Vitale, M. A., VanBeek, C., Spivack, J., Cheng, B., & Geller, J. A. (2011) · Geriatric Orthopaedic Surgery & Rehabilitation · doi:10.1177/2151458511417434 · Cited by 26
Prothrombin complex concentrate for the urgent reversal of warfarin. Assessment of a standard dosing protocol
Wozniak, M., Kruit, A., Padmore, R., Giulivi, A., & Bormanis, J. (2012) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2012.03.021 · Cited by 24
Managing Bleeding in Anticoagulated Patients in the Emergency Care Setting
Pollack, C. V. (2013) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2013.03.016 · Cited by 23
Management of Excessive Anticoagulant Effect Due to Vitamin K Antagonists
Dentali, F., & Crowther, M. A. (2008) · Hematology · doi:10.1182/asheducation-2008.1.266 · Cited by 23
Treating Warfarin-Related Intracerebral Hemorrhage
Hemphill, J. C. (2005) · Stroke · doi:10.1161/01.str.0000195152.46506.3e · Cited by 23
Prothrombin complex concentrate (Octaplex)
Carvalho, M. C., Rodrigues, A., Conceição, L. M., Galvão, M., & Ribeiro, L. C. (2012) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e328351250f · Cited by 22
Comparison between Prothrombin Complex Concentrate (PCC) and Fresh Frozen Plasma (FFP) for the Urgent Reversal of Warfarin in Patients with Mechanical Heart Valves in a Tertiary Care Cardiac Center.
Farsad, B. F., Golpira, R., Najafi, H., Totonchi, Z., Salajegheh, S., Bakhshandeh, H., & Hashemian, F. (2015) · Europe PMC (PubMed Central) · Cited by 22
Hibernation and hemostasis
de Vrij, E. L., Bouma, H. R., Henning, R. H., & Cooper, S. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1207003 · Cited by 21
Anti-Coagulant and Anti-Thrombotic Properties of Blacklip Abalone (Haliotis rubra): In Vitro and Animal Studies
Suleria, H. A. R., Masci, P. P., Zhao, K., Addepalli, R., Chen, W., Osborne, S. A., & Gobe, G. C. (2017) · Marine Drugs · doi:10.3390/md15080240 · Cited by 21
Stroke Prevention in Atrial Fibrillation: A Clinical Perspective on Trials of the Novel Oral Anticoagulants
Morais, J., & Caterina, R. D. (2016) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-015-6632-3 · Cited by 20

Authors: Hanley, J. P.
Affiliations: Royal Victoria Infirmary (GB)
Corresponding author: Hanley, J P
ORCID: Hanley, J P
Venue: Journal of Clinical Pathology
Publisher: BMJ
Published: 2004-10-27
Volume: 57
Issue: 11
Pages: 1132-1139
ISSN: 0021-9746 (ISSN-L)
1472-4146
DOI: 10.1136/jcp.2003.008904
PMC: PMC1770479
OpenAlex: W4237953286
Cited by: 215
References: 76
Citations by year: 2026: 2 · 2025: 4 · 2024: 7 · 2023: 6 · 2022: 7 · 2021: 10 · 2020: 9 · 2019: 4 · 2018: 7 · 2017: 12 · 2016: 14 · 2015: 14 · 2014: 6 · 2013: 16 · 2012: 11
FWCI: 1.39
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Pathology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Newcastle University ePrints (Newcastle Univesity)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Health Sciences › Medicine › Hematology › Blood transfusion and management
Keywords: warfarin reversal, oral anticoagulants, anticoagulant reversal, hemorrhage, overanticoagulation, northern regions
MeSH terms: Administration, Oral, Anticoagulants, Blood Coagulation, Blood Coagulation Factors, Child, Coagulants, Drug Administration Schedule, Factor VII, Hemorrhage, Humans, Plasma, Recombinant Proteins, Vitamin K, Warfarin, Factor VIIa, Practice Guidelines as Topic, Intracranial Hemorrhages

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Warfarin reversal

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks